Landscape Capital Management Cut By $561,614 Its Enanta Pharmaceuticals (ENTA) Holding; 5 Analysts Bullish Kinaxis Inc. (TSE:KXS)

January 22, 2018 - By Linda Rogers

Among 9 analysts covering Kinaxis Inc (TSE:KXS), 5 have Buy rating, 0 Sell and 4 Hold. Therefore 56% are positive. Kinaxis Inc had 38 analyst reports since August 7, 2015 according to SRatingsIntel. The company was downgraded on Thursday, August 17 by IBC. The rating was maintained by Scotia Capital with “Sector Perform” on Friday, November 4. BMO Capital Markets maintained it with “Outperform” rating and $74 target in Monday, October 17 report. The firm has “Buy” rating given on Friday, December 16 by TD Securities. The rating was maintained by TD Securities with “Buy” on Monday, May 1. The firm earned “Sector Perform” rating on Friday, May 13 by National Bank Canada. The firm earned “Outperform” rating on Monday, October 31 by RBC Capital Markets. RBC Capital Markets maintained it with “Outperform” rating and $82 target in Friday, November 18 report. The firm has “Sector Perform” rating by Scotia Capital given on Friday, October 14. The stock of Kinaxis Inc. (TSE:KXS) has “Sector Perform” rating given on Friday, November 18 by Scotia Capital. See Kinaxis Inc. (TSE:KXS) latest ratings:

17/08/2017 Broker: BMO Capital Markets Rating: Outperform Old Target: $95.00 New Target: $82.00 Target Down
17/08/2017 Broker: Canaccord Genuity Old Rating: Buy New Rating: Hold Old Target: $100.00 New Target: $75.00 Target Up
17/08/2017 Broker: IBC Old Rating: Outperform New Rating: Neutral Old Target: $100.00 New Target: $82.00 Downgrade
17/08/2017 Broker: Eight Capital Rating: Buy Old Target: $100.00 New Target: $90.00 Target Up
17/08/2017 Broker: Laurentian Rating: Hold Old Target: $96.00 New Target: $83.00 Target Down
17/08/2017 Broker: National Bank Canada Rating: Outperform Old Target: $100.00 New Target: $90.00 Target Up
17/08/2017 Broker: RBC Capital Markets Rating: Outperform Old Target: $100.00 New Target: $85.00 Target Up
17/08/2017 Broker: Scotia Capital Rating: Sector Perform Old Target: $87.00 New Target: $82.00 Target Down
17/08/2017 Broker: TD Securities Rating: Buy Old Target: $98.00 New Target: $93.00 Target Down

Landscape Capital Management Llc decreased Enanta Pharmaceuticals Inc (ENTA) stake by 65.7% reported in 2017Q3 SEC filing. Landscape Capital Management Llc sold 12,209 shares as Enanta Pharmaceuticals Inc (ENTA)’s stock rose 11.35%. The Landscape Capital Management Llc holds 6,375 shares with $298,000 value, down from 18,584 last quarter. Enanta Pharmaceuticals Inc now has $1.34B valuation. The stock increased 3.92% or $2.64 during the last trading session, reaching $69.96. About 73,010 shares traded. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) has risen 40.91% since January 22, 2017 and is uptrending. It has outperformed by 24.21% the S&P500.

Landscape Capital Management Llc increased Vwr Corp stake by 9,216 shares to 17,540 valued at $581,000 in 2017Q3. It also upped Chegg Inc (NYSE:CHGG) stake by 201,795 shares and now owns 228,656 shares. Ggp Inc was raised too.

Analysts await Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) to report earnings on February, 14. They expect $0.04 earnings per share, up 115.38% or $0.30 from last year’s $-0.26 per share. ENTA’s profit will be $765,009 for 437.25 P/E if the $0.04 EPS becomes a reality. After $1.86 actual earnings per share reported by Enanta Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -97.85% negative EPS growth.

Investors sentiment increased to 1.6 in Q3 2017. Its up 0.75, from 0.85 in 2017Q2. It increased, as 9 investors sold ENTA shares while 31 reduced holdings. 16 funds opened positions while 48 raised stakes. 12.10 million shares or 2.87% more from 11.77 million shares in 2017Q2 were reported. Envestnet Asset Mgmt, Illinois-based fund reported 2 shares. Weiss Multi reported 0.05% of its portfolio in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA). 950 are owned by Meeder Asset Mgmt. Proshare Advsrs Lc reported 12,098 shares or 0.01% of all its holdings. Invesco Limited stated it has 703,460 shares or 0.01% of all its holdings. Guggenheim Capital Limited Liability Corp has 27,763 shares. Credit Suisse Ag holds 0% of its portfolio in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) for 31,994 shares. Moreover, Mcclain Value Management Lc has 2.51% invested in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA). Utd Ser Automobile Association has 0% invested in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) for 33,800 shares. Alphamark Advisors Lc holds 0.51% or 25,500 shares. Employees Retirement System Of Ohio holds 0.01% or 20,644 shares in its portfolio. Aperio Ltd Liability holds 0% or 6,087 shares in its portfolio. State Common Retirement Fund invested in 49,418 shares or 0% of the stock. Rhumbline Advisers has 31,999 shares. State Street accumulated 720,999 shares.

Among 5 analysts covering Enanta Pharmaceuticals Inc (NASDAQ:ENTA), 2 have Buy rating, 1 Sell and 2 Hold. Therefore 40% are positive. Enanta Pharmaceuticals Inc had 20 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) earned “Buy” rating by TheStreet on Saturday, August 8. The firm has “Hold” rating by Robert W. Baird given on Friday, October 20. The rating was upgraded by JMP Securities to “Mkt Outperform” on Friday, October 23. As per Tuesday, January 2, the company rating was downgraded by RBC Capital Markets. As per Friday, August 7, the company rating was downgraded by Zacks. Robert W. Baird maintained Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) on Monday, November 20 with “Hold” rating. As per Tuesday, July 11, the company rating was upgraded by JMP Securities. The firm has “Buy” rating by RBC Capital Markets given on Monday, November 20. Barclays Capital downgraded it to “Underweight” rating and $16 target in Friday, October 23 report. On Thursday, April 28 the stock rating was downgraded by JMP Securities to “Market Perform”.

The stock decreased 2.19% or $1.7 during the last trading session, reaching $76. About 24,533 shares traded. Kinaxis Inc. (TSE:KXS) has 0.00% since January 22, 2017 and is . It has underperformed by 16.70% the S&P500.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>